Pulse Biosciences
PLSE
46 hedge funds and large institutions have $24.9M invested in Pulse Biosciences in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 5 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
7% more funds holding
Funds holding: 43 → 46 (+3)
0.5% more ownership
Funds ownership: 9.89% → 10.39% (+0.5%)
2% less capital invested
Capital invested by funds: $25.3M → $24.9M (-$401K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 2 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$497K |
| 3 |
BlackRock
New York
|
+$228K |
| 4 |
State Street
Boston,
Massachusetts
|
+$220K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$170K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$583K |
| 2 |
SCP
Silverleafe Capital Partners
Germantown,
Tennessee
|
-$500K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$216K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$141K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$90K |
PLSE Hedge Fund Activity: Q3 2018 in Review
46 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2018, worth a combined $24.9M — down 1.6% from $25.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PLSE positions and 5 closed out — a net gain of 3 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.1M. The largest seller was Wells Fargo, cutting an estimated $583K.
- 46 institutional investors held Pulse Biosciences (PLSE) as of Q3 2018, up from 43 in Q2 2018.
- Funds reported $24.9M of Pulse Biosciences stock for Q3 2018, down 1.6% quarter-over-quarter.
- 8 funds opened new Pulse Biosciences positions in Q3 2018 and 5 closed out, a net change of +3 holders.
- The largest Pulse Biosciences buyer in Q3 2018 was Vanguard Group, an estimated $1.1M added.
- The largest Pulse Biosciences seller in Q3 2018 was Wells Fargo, an estimated $583K sold.
Based on aggregated 13F filings for Q3 2018.